Pharmaceuticals, Biotechnology and Life Sciences
Professor Shechtman joins fellow Nobel Prize laureate Professor Roger Kornberg to advance the development of treatments for Autism Spectrum Disorder…
– Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 – – Additional…
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent…
Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or…
WARREN, N.J., April 15, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced the…
In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope KEY FIGURESRevenue1st…
BERWYN, Pa., April 15, 2025 (GLOBE NEWSWIRE) — AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical…
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of…
LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
– Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot…